We are live on ! Find out more

Alexandria Real Estate Equities

ARE

Market cap $8.94B

51.96 USD

+0.82

1.6%

At close Updated Sep 14, 4:00 PM EDT

Pre-market

After hours

51.96

0.00

0%

1 day

1.6%

5 days

-0.61%

1 month

7.94%

3 months

-0.8%

6 months

7.56%

Year to date

6.11%

1 year

-39.28%

5 years

-73.95%

10 years

-50.6%

About: Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Employees: 514

Real Estate Office REIT

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 33.3%

Neutral 53.3%

Negative 13.3%

2 REITs, $0 I'd Invest: Here's My Case Against The Crowd Favorites

Most equity REITs are uninvestable for high dividend-seeking investors. However, there are some gems to be found. Bargain-hunting high-quality names could be a reasonable approach.

2 REITs, $0 I'd Invest: Here's My Case Against The Crowd Favorites

Alexandria Real Estate: Despite Headwinds, It Remains A Buy

Alexandria Real Estate Equities (ARE) remains a Buy, supported by a compelling margin of safety despite headwinds. ARE faces persistent supply-demand imbalances in key life science markets, but recent improvements in venture funding and leasing trends offer cautious optimism. Alexandria is responding defensively — asset sales, a 45% dividend cut, lower G&A, and a pivot to JV capital — as credit downgrades reflect the same headwinds already priced in.

Alexandria Real Estate: Despite Headwinds, It Remains A Buy

Alexandria Real Estate: The Risk Was At $220, Not At $51

Alexandria Real Estate has declined 75% in five years due to oversupply, higher rates, and a biotech funding slowdown. Despite recent negative rental rate changes and falling occupancy, ARE's best-in-class assets are positioned for a flight to quality as supply dries up. Life sciences market fundamentals are stabilizing, with construction pipelines shrinking and key markets showing early signs of recovery.

Alexandria Real Estate: The Risk Was At $220, Not At $51

Everyone Is Avoiding These REITs: That's The Opportunity

Some of the most hated REIT sectors may offer the biggest upside. European REITs trade at unusually steep NAV discounts. Life science and tower REITs could recover as sentiment turns.

Everyone Is Avoiding These REITs: That's The Opportunity

The Motley Fool

Alexandria Real Estate Chief Accounting Officer Sells 10,000 Shares

The Aug. 31 transaction was valued at $509,300. The sale involved shares equal to 9% of the stake held directly by the insider prior to the transaction.

Alexandria Real Estate Chief Accounting Officer Sells 10,000 Shares

3 REITs To Buy Before The Fed Likely Cuts Rates In 2027

Rate cuts may return sooner than the market expects. SAFE and STHO could rebound sharply if rates fall. Alexandria may benefit from both lower rates and improving demand.

3 REITs To Buy Before The Fed Likely Cuts Rates In 2027

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

PASADENA, Calif., Sept. 4, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation clusters, today recognizes Blood Cancer Awareness Month by highlighting its strategic investments and tenants developing life-saving therapies in hematology and oncology, as well as the company's longstanding mission-critical engagement with the nation's leading nonprofits focused on blood cancers.

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

Alexandria Real Estate: We've Already Seen The Bottom, Next Is The Retest

Alexandria Real Estate Equities, Inc. (ARE) is deeply undervalued, but technical entry timing is critical for optimal returns. ARE's FFO faces near-term headwinds from major lease expirations in 2027, with recovery expected as new leases and projects ramp up. I target a $45 average entry, buying in tranches on further weakness or a breakout above $55, to balance value and momentum.

Alexandria Real Estate: We've Already Seen The Bottom, Next Is The Retest

Zacks Investment Research

Alexandria Real Estate Equities (ARE) Up 5.7% Since Last Earnings Report: Can It Continue?

Alexandria Real Estate Equities (ARE) reported earnings 30 days ago. What's next for the stock?

Alexandria Real Estate Equities (ARE) Up 5.7% Since Last Earnings Report: Can It Continue?

Median Implied Cap Rate For U.S. Equity REITs Climbs Further In Q2 2026

The median implied capitalization rate for US equity real estate investment trusts increased 6 bps QoQ and 2 bps YoY to 7.8% in Q2, according to data compiled by S&P Global Market Intelligence. Hotel REITs posted the highest median implied cap rate among US equity REITs at 11.2%, maintaining their lead for another quarter. Office REITs followed, recording a median implied cap rate of 10.7%.

Median Implied Cap Rate For U.S. Equity REITs Climbs Further In Q2 2026

See News Rankings

Price charts implemented using Lightweight Charts™